Company Description
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.
The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.
It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings.
In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services.
Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services.
The company sells its products through field sales professionals, channel partners, and value-added resellers.
American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
| Country | United States |
| Founded | 2006 |
| IPO Date | Sep 17, 2020 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 1,104 |
| CEO | Ido Schoenberg |
Contact Details
Address: 75 State Street, 26th Floor Boston, Massachusetts 02109 United States | |
| Phone | 617 204 3500 |
| Website | business.amwell.com |
Stock Details
| Ticker Symbol | AMWL |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.00 |
| CIK Code | 0001393584 |
| CUSIP Number | 03044L105 |
| ISIN Number | US03044L1052 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ido Schoenberg M.D. | Chairman and Chief Executive Officer |
| Dr. Roy Schoenberg M.D., M.P.H. | Executive Vice Chairman |
| Phyllis I. Gotlib | President of Amwell International |
| Vukasin Paunovich | Executive Vice President of Enterprise Platforms |
| Kathy Weiler | Executive Vice President and Chief Commercial and Growth Officer |
| Mark J. Hirschhorn CPA | Chief Financial Officer |
| Kurt Knight | Chief Operating Officer |
| Paul Francis McNeice | Vice President of Accounting |
| Sue Dooley | Head of Investor Relations |
| Bradford F. Gay J.D. | Senior Vice President and General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 18, 2024 | 8-K | Current Report |
| Dec 2, 2024 | 144 | Filing |
| Dec 2, 2024 | 144 | Filing |
| Dec 2, 2024 | 144 | Filing |
| Dec 2, 2024 | 144 | Filing |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 6, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 5, 2024 | 144 | Filing |
| Nov 4, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |